These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 17699467
1. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Kavanagh D, Richards A, Fremeaux-Bacchi V, Noris M, Goodship T, Remuzzi G, Atkinson JP. Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467 [No Abstract] [Full Text] [Related]
2. Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes. Le Quintrec M, Roumenina L, Noris M, Frémeaux-Bacchi V. Semin Thromb Hemost; 2010 Sep; 36(6):641-52. PubMed ID: 20865641 [Abstract] [Full Text] [Related]
5. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS). Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L. Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822 [Abstract] [Full Text] [Related]
12. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C, French Society of Pediatric Nephrology. J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974 [Abstract] [Full Text] [Related]
13. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation. Kavanagh D, Burgess R, Spitzer D, Richards A, Diaz-Torres ML, Goodship JA, Hourcade DE, Atkinson JP, Goodship TH. Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771 [Abstract] [Full Text] [Related]
14. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP. J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990 [Abstract] [Full Text] [Related]
15. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, Fremeaux-Bacchi V, Trouw LA, Blom AM. Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897 [Abstract] [Full Text] [Related]
18. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. Dragon-Durey MA, Blanc C, Marliot F, Loirat C, Blouin J, Sautes-Fridman C, Fridman WH, Frémeaux-Bacchi V. J Med Genet; 2009 Jul; 46(7):447-50. PubMed ID: 19435718 [Abstract] [Full Text] [Related]
19. Plasmatherapy in atypical hemolytic uremic syndrome. Loirat C, Garnier A, Sellier-Leclerc AL, Kwon T. Semin Thromb Hemost; 2010 Sep; 36(6):673-81. PubMed ID: 20865645 [Abstract] [Full Text] [Related]